JBM HEALTHCARE Reports Annual Results with Profit Attributable to Owners Reaching Approximately HK$201 Million

Stock News06-22

JBM HEALTHCARE (SEHK: 2161) has announced its financial results for the year ended March 31, 2026. The company reported revenue of approximately HK$835 million, representing an increase of about 6.7% year-on-year.

Profit attributable to equity holders of the company was around HK$201 million, marking a rise of approximately 1.9% compared to the previous year. Earnings per share stood at 24.63 HK cents, with a final dividend of 7.35 HK cents per share declared.

The company attributed the revenue growth primarily to the robust performance of its Branded Medicines and Branded Chinese Medicine segments, which was partially offset by a weaker performance in the Health Supplements division. Supported by solid market demand and effective marketing initiatives, the Branded Medicines segment saw a revenue increase of HK$7.8 million, reflecting stable sales momentum and enhanced promotional efforts. Meanwhile, the Branded Chinese Medicine segment recorded a revenue growth of HK$62.9 million.

These gains were partly offset by a revenue decline of HK$18.4 million in the Health Supplements segment, primarily due to a refined and simplified product mix and softer consumer demand. The three segments contributed 34%, 56%, and 10% respectively to the total revenue.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107781328?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 22:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107781328","market":"fut","top_or_hot":-1,"title":"JBM HEALTHCARE Reports Annual Results with Profit Attributable to Owners Reaching Approximately HK$201 Million","media":"Stock News","content":"<p><b>JBM HEALTHCARE</b> (<b>SEHK: 2161</b>) has announced its financial results for the year ended March 31, 2026. The company reported revenue of approximately HK$835 million, representing an increase of about 6.7% year-on-year.<br><br>Profit attributable to equity holders of the company was around HK$201 million, marking a rise of approximately 1.9% compared to the previous year. Earnings per share stood at 24.63 HK cents, with a final dividend of 7.35 HK cents per share declared.<br><br>The company attributed the revenue growth primarily to the robust performance of its Branded Medicines and Branded Chinese Medicine segments, which was partially offset by a weaker performance in the Health Supplements division. Supported by solid market demand and effective marketing initiatives, the Branded Medicines segment saw a revenue increase of HK$7.8 million, reflecting stable sales momentum and enhanced promotional efforts. Meanwhile, the Branded Chinese Medicine segment recorded a revenue growth of HK$62.9 million.<br><br>These gains were partly offset by a revenue decline of HK$18.4 million in the Health Supplements segment, primarily due to a refined and simplified product mix and softer consumer demand. The three segments contributed 34%, 56%, and 10% respectively to the total revenue.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JBM HEALTHCARE Reports Annual Results with Profit Attributable to Owners Reaching Approximately HK$201 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJBM HEALTHCARE Reports Annual Results with Profit Attributable to Owners Reaching Approximately HK$201 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-22 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>JBM HEALTHCARE</b> (<b>SEHK: 2161</b>) has announced its financial results for the year ended March 31, 2026. The company reported revenue of approximately HK$835 million, representing an increase of about 6.7% year-on-year.<br><br>Profit attributable to equity holders of the company was around HK$201 million, marking a rise of approximately 1.9% compared to the previous year. Earnings per share stood at 24.63 HK cents, with a final dividend of 7.35 HK cents per share declared.<br><br>The company attributed the revenue growth primarily to the robust performance of its Branded Medicines and Branded Chinese Medicine segments, which was partially offset by a weaker performance in the Health Supplements division. Supported by solid market demand and effective marketing initiatives, the Branded Medicines segment saw a revenue increase of HK$7.8 million, reflecting stable sales momentum and enhanced promotional efforts. Meanwhile, the Branded Chinese Medicine segment recorded a revenue growth of HK$62.9 million.<br><br>These gains were partly offset by a revenue decline of HK$18.4 million in the Health Supplements segment, primarily due to a refined and simplified product mix and softer consumer demand. The three segments contributed 34%, 56%, and 10% respectively to the total revenue.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02161","symbol_name":"健倍苗苗","start_time":0,"source_url":"","article_id":"1107781328","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107781328","pubTimestamp":1782138742,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"JBM HEALTHCARE (SEHK: 2161) has announced its financial results for the year ended March 31, 2026. The company reported revenue of approximately HK$835 million, representing an increase of about 6.7%...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02161":"健倍苗苗","BK1191":"制药","BK1606":"中医药概念"},"translate_title":"健邦医疗公布全年业绩拥有人应佔溢利达约2.01亿港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02161":1},"content_text":"JBM HEALTHCARE (SEHK: 2161) has announced its financial results for the year ended March 31, 2026. The company reported revenue of approximately HK$835 million, representing an increase of about 6.7% year-on-year.Profit attributable to equity holders of the company was around HK$201 million, marking a rise of approximately 1.9% compared to the previous year. Earnings per share stood at 24.63 HK cents, with a final dividend of 7.35 HK cents per share declared.The company attributed the revenue growth primarily to the robust performance of its Branded Medicines and Branded Chinese Medicine segments, which was partially offset by a weaker performance in the Health Supplements division. Supported by solid market demand and effective marketing initiatives, the Branded Medicines segment saw a revenue increase of HK$7.8 million, reflecting stable sales momentum and enhanced promotional efforts. Meanwhile, the Branded Chinese Medicine segment recorded a revenue growth of HK$62.9 million.These gains were partly offset by a revenue decline of HK$18.4 million in the Health Supplements segment, primarily due to a refined and simplified product mix and softer consumer demand. The three segments contributed 34%, 56%, and 10% respectively to the total revenue.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107781328","isCrawlerRequest":true}